Product
Relizorb
1 clinical trial
2 indications
Indication
Multi-Organ FailureIndication
Critical IllnessClinical trial
Single-center, Open-label, Prospective Randomized (Double-Blind) Study on the Use of ReliZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi Organ FailureStatus: Withdrawn, Estimated PCD: 2023-07-30